NCT04397978
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must have 4-10 brain metastases
Exclusions: Patients with brain metastasis that are not amenable to stereotactic radiosurgery (SRS); Patients with previous SRS or surgery on the same lesion; Patients with leptomeningeal disease
https://ClinicalTrials.gov/show/NCT04397978